NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Cytokinetics, Incorporated (NASDAQ:CYTK) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/cytokinetics-incorporated-lawsuit-submission-form-2?prid=175161&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call […]

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=175158&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Blazpay enters Phase 3 after raising 1 million dollars and surpassing 139 million tokens sold, marking another major milestone in its presale journey GlobeNewswire November 03, 2025 PANAMA CITY, Nov. 03, 2025 (GLOBE NEWSWIRE) — Blazpay's AI Crypto Presale 2025 has reached a significant milestone, raising $1 million in Phase 3 with 137 million BLAZ

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your Fluor Corporation (NYSE:FLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fluor-corporation-lawsuit-submission-form?prid=175155&wire=1&utm_campaign=5 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

TURKU, FI / ACCESS Newswire / November 3, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) – Having achieved all primary endpoints and secured FDA alignment, Faron formally concludes enrolment of the BEXMAB Phase 2 trial as Company’s focus shifts to a registrational trial TURKU, FINLAND – Faron Pharmaceuticals Ltd. (AIM:FARN, First North:FARON), a clinical-stage biopharmaceutical company focused

NEW YORK, NY / ACCESS Newswire / November 3, 2025 / If you suffered a loss on your WPP plc (NYSE:WPP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/wpp-plc-lawsuit-submission-form?prid=175152&wire=1&utm_campaign=2 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

Nokia and OneLayer partner to accelerate secure private 5G/LTE adoption for utilities GlobeNewswire November 03, 2025 Press ReleaseNokia and OneLayer partner to accelerate secure private 5G/LTE adoption for utilities Nokia's secure mission-critical private networks combined with OneLayer's OT asset visibility and protection help utilities modernize grids with secure 5G/LTE. 3 November 2025Espoo, Finland – Nokia

VIVOLTA expands regenerative implant manufacturing capability with dedicated facility GlobeNewswire November 03, 2025 VIVOLTA expands regenerative implant manufacturing capability with dedicated facility New High Tech Campus Eindhoven site to enable electrospun medical implant production at scale Growth Momentum: Reflecting VIVOLTA's sustained commercial growth and the increasing demand from customers for industrial-scale manufacturing of electrospun medical

AAVantgarde Closes $141 Million Series B Financing to Advance its Clinical Programs in Stargardt Disease and Usher 1B Syndrome GlobeNewswire November 03, 2025 LONDON and MILAN, Nov. 03, 2025 (GLOBE NEWSWIRE) — AAVantgarde Bio (AAVantgarde), a clinical-stage, biotechnology company pioneering therapies for inherited retinal diseases (IRDs), today announced the successful closing of a $141 million

Darktrace Appoints Suman Raju as Chief Financial Officer and Hein Hellemons as Chief Revenue Officer Seasoned executives bring 40+ years of combined leadership across finance and go-to-market functions and enterprise software technology companies. Appointments advance Darktrace's strategy to deepen customer value, scale its global operations, and deliver sustainable growth. GlobeNewswire November 03, 2025 Cambridge, UK,